Iranian pilgrim saved from heart attack in Makkah by Saudi medical team
MAKKAH — A Saudi medical team in Makkah saved the life of an Iranian pilgrim who suffered a severe heart attack, performing emergency surgery within the critical first hour and enabling him to continue his Hajj journey.
The incident underscores Saudi Arabia's ongoing commitment to providing high-quality, specialized medical care to pilgrims through advanced facilities and qualified national personnel.
According to a statement from the Makkah Health Cluster, the pilgrim arrived at the emergency department of King Abdullah Medical City suffering from acute chest pain caused by a severe heart attack.
The medical team swiftly assessed the situation and performed immediate surgery within the so-called "golden hour," a vital period for preventing complications.
The statement emphasized that the successful operation was carried out under Saudi Arabia's urgent care protocols, part of the national healthcare model designed to provide rapid interventions.
The patient is now in stable condition, with no complications reported, and is expected to rejoin his Hajj group in the coming days to complete his pilgrimage.
Ali Reza Bayat, head of Iran's Hajj and Pilgrimage Organization, praised the Kingdom's efforts to ensure the safety and well-being of pilgrims during a meeting with Saudi Interior Minister Prince Abdulaziz bin Saud bin Naif on Wednesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Saudi Gazette
5 hours ago
- Saudi Gazette
Shoura council urges culture ministry to expand music and cinema programs, calls for arts school independence
Saudi Gazette report RIYADH — The Shoura Council on Monday called on the Ministry of Culture to broaden its academic programs in music, cinema, theater, and performing arts, while also working toward full financial and administrative independence for its cultural commissions to ensure their sustainability and effectiveness. During its 39th regular session, the council urged the ministry's Museums Commission to upgrade exhibits at the National Museum to reflect recent archaeological discoveries, and called for an annual publishing plan for Saudi literary works. It also encouraged coordination with the Ministry of Education to revive school theater programs and stimulate domestic theatrical activity. The council issued several other recommendations across government sectors. It asked the National Center for Mental Health Promotion to establish a unified national framework to accredit public and private mental health providers and monitor psychological consultation apps, and to support school health awareness efforts in partnership with the Ministry of Health. Regarding the National Institute for Educational Professional Development, the council proposed recognizing teacher preparation programs in employment standards and called for the formation of professional learning communities in also pressed the General Authority for Competition to implement preemptive deterrents against anti-competitive practices and urged faster integration with the government's 'Etimad' it called on the General Authority for Statistics to enhance the release of economic and development data and coordinate to boost Saudi talent placement in global council advocated for attracting and localizing Saudi capital abroad to align with domestic investment opportunities, and advised resolving overlapping jurisdictions to improve the investment climate ahead of Expo sports, the council asked the Sports Boulevard Foundation to comply with Cabinet reporting guidelines and improve services at its also reviewed the Ministry of Health's annual report, recommending equal healthcare access, better availability of essential medicines, and direct user feedback through the 'Sehhaty' emphasized improving capabilities at specialty hospitals in remote areas and incentivizing skilled also proposed new regulatory frameworks for healthcare practitioners creating media content and stricter oversight of health content on social suggestions included enabling remote consultations with central hospitals, and developing medical wellness resorts to utilize Saudi Arabia's natural assets for sustainable economic and healthcare education and investment, the council called on the Ministry of Industry and Mineral Resources to evolve regional incentive frameworks and align with local sectoral also urged the Ministry of Sports to fast-track club privatization, expand school and university sports, and foster talent pipelines tied to professional stressed the need for greater private investment in sports, enhanced sports medicine, and a professional media ecosystem to support Saudi Arabia's global sporting called for a youth-focused strategy for community and competitive sports, and for nurturing talent across all age categories to elevate Saudi athletes on the global stage.
Saudi Gazette
10 hours ago
- Saudi Gazette
Health official warns against unsupervised use of weight-loss drugs like Ozempic, Mounjaro
Saudi Gazette report RIYADH — Saudi Deputy Minister of Health for Population Health, Dr. Abdullah Asiri, has issued a public warning against the unsupervised use of anti-obesity medications such as Ozempic and Mounjaro, emphasizing the serious health risks associated with misuse. In a post on his official X account, Dr. Asiri cautioned that reckless reliance on these drugs or drastic dietary changes — such as extreme calorie restriction or rigid vegan diets — can result in nutritional imbalances that negatively affect overall health. He noted that dietary supplements are generally unnecessary when one follows a well-balanced and complete diet. He also advised the public to avoid foods high in fat and irritating spices, and to incorporate regular physical activity, such as walking and exercise, into their daily routines to maintain a healthy lifestyle without resorting to quick fixes or risky solutions. His remarks come amid growing concern from medical professionals about the increasing popularity of weight-loss drugs being used without prescriptions, raising red flags over long-term safety and potential side effects.
Saudi Gazette
5 days ago
- Saudi Gazette
SFDA approves 'Winrevair' for rare pulmonary hypertension treatment
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of Winrevair (sotatercept) for the treatment of adult patients with World Health Organization (WHO) Functional Class II to III pulmonary arterial hypertension (PAH). Previously designated as an orphan drug under SFDA's Orphan Drugs Program, Winrevair addresses a critical need for patients with this life-threatening condition. PAH is characterized by the narrowing and thickening of blood vessels in the lungs, leading to symptoms such as shortness of breath, chest pain, and fatigue. Winrevair introduces a novel mechanism of action by inhibiting activin signaling, which plays a role in the thickening of pulmonary arteries. By restoring cellular growth balance, the drug improves blood flow in the lungs, reduces strain on the heart, and enhances oxygen delivery and physical endurance, thereby improving patients' quality of life. The SFDA confirmed that the drug's approval followed a comprehensive evaluation of its efficacy, safety, and quality, meeting all regulatory requirements. Clinical trials demonstrated a statistically significant and clinically meaningful reduction in the risk of disease progression or death in WHO Class II–III patients. The most common side effects reported were headache, nosebleeds, and skin itching, which were generally mild and manageable. The SFDA reiterated its commitment to supporting access to effective treatments, especially in the rare and difficult-to-treat disease space, which often suffers from limited therapeutic options. The authority's Orphan Drugs Program plays a strategic role in advancing pharmaceutical innovation and addressing unmet medical needs. Under the program, orphan drugs are defined as those intended to treat diseases affecting fewer than five individuals per 10,000 people in Saudi Arabia. The program offers benefits to pharmaceutical companies, including pre-submission meetings, priority review, and scientific consultations.
